Rx Redefined

Arroyo Grande, CA · Founded 2018 · Privately Held (backing)

Developer of medical supply and billing management platform designed to create transparency between patients and physicians. Rx Redefined is based in Arroyo Grande, CA and was founded in 2018. It was valued at $77 million at its later-stage round in Dec 2024, the last priced event on record. It has raised $35.6 million across 4 recorded rounds; the latest was a $21.5 million early-stage round in Dec 2024.

PMV mark · valuation
$77.0M
Oct 2026
Priced at
its later-stage round
Dec 2024
Total raised
$35.6M
Last round
Early Stage VC
Dec 2024
What is Rx Redefined worth?
$77.0MPrivateMarketView mark · Oct 2026

Valued at $77.0M at its later-stage round, Dec 2024. Nothing has traded since.

Free account
More of Rx Redefined with a free account
  • ·Watch Rx Redefined: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Rx Redefined funding history

4 rounds
DateRoundRaisedPost-money
Dec 2024Early Stage VC$21.5M▮
Aug 2022Early Stage VC$8.0M▮
May 2021Seed Round$3.2M▮
Jan 2021Seed Round$3.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Rx Redefined valuation

Rx Redefined was valued at $77 million at its later-stage round in Dec 2024. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Rx Redefined raised?

Rx Redefined has raised $35.6 million across 4 recorded rounds since 2021. The largest was an $8 million early-stage round in Aug 2022; the most recent was a $21.5 million early-stage round in Dec 2024.

Rx Redefined has filed 4 Form Ds with the SEC since 2021, most recently in Dec 2024 ($21.5 million sold to 8 investors).

How Rx Redefined's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Rx Redefined, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Rx Redefined

What is Rx Redefined worth?
Rx Redefined is valued at $77.0M as of Oct 2026. Valued at $77.0M at its later-stage round, Dec 2024. Nothing has traded since.
How much has Rx Redefined raised?
Rx Redefined has raised $35.6M in total funding across 4 recorded rounds.
When did Rx Redefined last raise?
Rx Redefined last raised in Dec 2024 (Early Stage VC), raising $21.5M.